TickerFactsScreenerDevelopers

Indivior Pharmaceuticals, Inc. (INDV) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2022: -$4.00M2023: -$300.00M2024: $36.00M2025: -$27.00M-$27.00M
2022Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$27.00M-175.0%
2024$36.00M+112.0%
2023-$300.00M-7400.0%
2022-$4.00M—